Oncotarget is a free-access medical journal that is published weekly. The journal was started in 2010. It focuses on oncology. It is published by Impact Journals and is indexed by Scopus, the Science Citation Index, and Index Medicus. The editors-in-chief of Oncotarget are Mikhail Blagosklonny and Andrei Gudkov. Gudkov is a professor and the senior vice president for basic research at the Roswell Park Cancer Institute. Blagosklonny is a professor of oncology at the Institute. He is a distinguished scholar. He has written more than 200 papers that have appeared in peer-reviewed journals over the course of his career. He has also served as the associate editor of various journals including Autophagy, PLOS ONE, and the American Journal of Pathology. Read more about Oncotarget at Google Scholar.
Several members of the editorial board of the journal have won prestigious prizes in the scientific field including the Breakthrough Prize and the Lasker Prize. The journal has expanded to include other medical fields such as cell biology, metabolism, endocrinology, neuroscience, and pharmacology. This is because the editors saw the need to include other areas that closely relate to the field of oncology. They are able to bolster research and discoveries in the field in general by doing so. Oncotarget has a reach of ten thousand cities today. The number continues to grow each day. The journal has had an average impact factor of 5.4 over the past five years. This has made it one of the top journals in the medical field. Oncotarget has been ranked highly by Scopus in the oncology and medicine categories since 2011. It is the top journal among all documents on Oncology.
The journal makes scientific papers available in a fast manner because it is published online and has free-access. This means that anybody from anywhere in the world can access it. It also makes it possible for discoveries to be shared quickly because of the above reasons. This has helped to improve the medical field since the journal has an enormous impact factor. Oncotarget has helped to foster collaboration between researchers from different fields by choosing to expand beyond oncology.
Learn more: https://www.ncbi.nlm.nih.gov/pmc/journals/1558/